v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited) - USD ($)
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Income Statement [Abstract]    
INCOME FROM EQUITY METHOD INVESTMENT - LAB SERVICES MSO   $ 392,677
OTHER OPERATING EXPENSES:    
Advertising and marketing expenses $ 209,846 71,150
Professional fees 1,581,951 1,632,215
Compensation and related benefits 223,416 309,022
Amortization of intangible assets 563,000
Other general and administrative expenses 142,913 165,713
Total Other Operating Expenses 2,721,126 2,178,100
LOSS FROM OPERATIONS (2,721,126) (1,785,423)
OTHER EXPENSE    
Interest expense - amortization of debt discount and debt issuance costs (189,417) (283,755)
Interest expense - other (82,029) (81,956)
Change in fair value of derivative liability (1,276,889) (114,360)
Other expense (107,219) (1,186)
Total Other Expense (1,655,554) (481,257)
LOSS BEFORE INCOME TAXES (4,376,680) (2,266,680)
INCOME TAXES
NET LOSS FROM CONTINUING OPERATIONS (4,376,680) (2,266,680)
NET LOSS FROM DISCONTINUED OPERATIONS (103,015) (215,431)
NET LOSS (4,479,695) (2,482,111)
LESS: NET LOSS ATTRIBUTABLE TO NONCONTROLLING INTEREST
NET LOSS AFTER NONCONTROLLING INTEREST (4,479,695) (2,482,111)
DEEMED CONTRIBUTION ON EXCHANGE OF EQUITY INSTRUMENTS   162,473
NET LOSS ATTRIBUTABLE TO AVALON GLOBOCARE CORP. COMMON SHAREHOLDERS $ (4,479,695) $ (2,319,638)
NET LOSS PER COMMON SHARE ATTRIBUTABLE TO AVALON GLOBOCARE CORP. COMMON SHAREHOLDERS:    
Basic, continuing operations (in Dollars per share) $ (0.49) $ (1.3)
Diluted, continuing operations (in Dollars per share) (0.49) (1.3)
Basic, discontinued operations (in Dollars per share) (0.01) (0.13)
Diluted, discontinued operations (in Dollars per share) (0.01) (0.13)
Basic (in Dollars per share) (0.5) (1.43)
Diluted (in Dollars per share) $ (0.5) $ (1.43)
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:    
Basic (in Shares) 8,963,998 1,624,629
Diluted (in Shares) 8,963,998 1,624,629
COMPREHENSIVE LOSS:    
NET LOSS $ (4,479,695) $ (2,482,111)
OTHER COMPREHENSIVE (LOSS) INCOME FROM CONTINUED OPERATIONS    
Unrealized foreign currency translation (loss) gain (311) 279
COMPREHENSIVE LOSS (4,480,006) (2,481,832)
LESS: COMPREHENSIVE LOSS ATTRIBUTABLE TO NONCONTROLLING INTEREST
COMPREHENSIVE LOSS ATTRIBUTABLE TO AVALON GLOBOCARE CORP. COMMON SHAREHOLDERS $ (4,480,006) $ (2,481,832)